-+ 0.00%
-+ 0.00%
-+ 0.00%

ABCELLERA BIOLOGICS INC - PHASE 1 TRIAL FOR ABCL635 EXPECTED TO START IN Q3 2025

Reuters·05/14/2025 21:00:00

Please log in to view news